211 related articles for article (PubMed ID: 31898819)
1. A study comparing the clinical and hormonal profile of late onset and persistent acne in adult females.
Sardana K; Bansal P; Sharma LK; Garga UC; Vats G
Int J Dermatol; 2020 Apr; 59(4):428-433. PubMed ID: 31898819
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne.
Bansal P; Sardana K; Arora P; Khurana A; Garga UC; Sharma L
Dermatol Ther; 2020 Nov; 33(6):e13974. PubMed ID: 33185003
[TBL] [Abstract][Full Text] [Related]
3. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
Timpatanapong P; Rojanasakul A
J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062
[TBL] [Abstract][Full Text] [Related]
4. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
5. A prospective study examining isolated acne and acne with hyperandrogenic signs in adult females.
Bansal P; Sardana K; Sharma L; Garga UC; Vats G
J Dermatolog Treat; 2021 Nov; 32(7):752-755. PubMed ID: 31868042
[TBL] [Abstract][Full Text] [Related]
6. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
[TBL] [Abstract][Full Text] [Related]
7. Is acne a sign of androgen excess disorder or not?
Uysal G; Sahin Y; Unluhizarci K; Ferahbas A; Uludag SZ; Aygen E; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():21-25. PubMed ID: 28178574
[TBL] [Abstract][Full Text] [Related]
8. The role of antimullerian hormone in the hormonal workup of women with persistent acne.
Sardana K; Singh C; Narang I; Bansal S; Garg VK
J Cosmet Dermatol; 2016 Dec; 15(4):343-349. PubMed ID: 27320497
[TBL] [Abstract][Full Text] [Related]
9. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
[TBL] [Abstract][Full Text] [Related]
10. Assessment of androgens in women with adult-onset acne.
Seirafi H; Farnaghi F; Vasheghani-Farahani A; Alirezaie NS; Esfahanian F; Firooz A; Ghodsi SZ
Int J Dermatol; 2007 Nov; 46(11):1188-91. PubMed ID: 17988341
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
13. Hyperandrogenemia in patients presenting with acne.
Slayden SM; Moran C; Sams WM; Boots LR; Azziz R
Fertil Steril; 2001 May; 75(5):889-92. PubMed ID: 11334899
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
[TBL] [Abstract][Full Text] [Related]
15. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome.
Franik G; Bizoń A; Włoch S; Kowalczyk K; Biernacka-Bartnik A; Madej P
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4411-4418. PubMed ID: 30058676
[TBL] [Abstract][Full Text] [Related]
16. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
18. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
19. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
Mango D; Ricci S; Manna P; Miggiano GA; Serra GB
Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Study Examining Trigger Factors and Hormonal Abnormalities in Adult Female Acne.
Bansal P; Sardana K; Vats G; Sharma L; Garga UC; Khurana A
Indian Dermatol Online J; 2020; 11(4):544-550. PubMed ID: 32832440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
